Clinical Trials Browser

Phase 2 × Solid Malignant Tumors × regorafenib × Clear all

NCT06246643 2026-03-19

A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies

Phase 2 Active not recruiting

Solid Malignant Tumors